Detection of IL-17A-producing peripheral blood monocytes in Langerhans cell histiocytosis patients

Clinical Immunology

Volumn 153, Issue 1, 2014, Pages 112-122

  Lourda, Magda ^a   Olsson Åkefeldt, Selma ^a   Gavhed, Désirée ^a   Björnfot, Sofia ^a   Clausen, Niels ^b   Hjalmars, Ulf ^c   Sabel, Magnus ^d,e   Tazi, Abdellatif ^f   Aricò, Maurizio ^g   Delprat, Christine ^h,i,j,k,l   Henter, Jan Inge ^a   Svensson, Mattias ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^d QUEEN SILVIA CHILDREN'S HOSPITAL   (Sweden)

^e SAHLGRENSKA ACADEMY AT UNIVERSITY OF GOTHENBURG   (Sweden)

^f UNIVERSITÉ PARIS DESCARTES   (France)

^g ISTITUTO TOSCANO TUMORI   (Italy)

^h Univ Claude Bernard   (France)

ⁱ UNIVERSITÉ DE LYON   (France)

^j UNIVERSITÉ DE LYON   (France)

^k UNIVERSITÉ LYON 1   (France)

^l INSTITUT UNIVERSITAIRE DE FRANCE   (France)

more..

Author keywords

Interleukin 17A; ; Langerhans cell histiocytosis; ; Monocytes; ; Retinoic acid orphan receptor C; Retinoic acid orphan receptor t;

Indexed keywords

CD14 ANTIGEN; CD16 ANTIGEN; CD19 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD66B ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; HLA DR ANTIGEN; INTERLEUKIN 17; INTERLEUKIN 23; IONOMYCIN; LYMPHOCYTE ANTIGEN; RETINOID RELATED ORPHAN RECEPTOR GAMMA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; BONE MARROW CELL; CELL ISOLATION; CELL STRUCTURE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; INFANT; LANGERHANS CELL HISTIOCYTOSIS; LYMPHOCYTE SUBPOPULATION; MALE; MONOCYTE; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; RNA EXTRACTION; SCHOOL CHILD; UPREGULATION;

INTERLEUKIN-17A;; LANGERHANS CELL HISTIOCYTOSIS;; MONOCYTES;; RETINOIC ACID ORPHAN RECEPTOR C; RETINOIC ACID ORPHAN RECEPTOR ΓT;;

ADOLESCENT; ADULT; ANTIGENS, CD14; CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; IMMUNOPHENOTYPING; INFANT; INTERLEUKIN-17; LEUKOCYTE COUNT; MALE; MONOCYTES; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; TRANSCRIPTION, GENETIC; YOUNG ADULT;

EID: 84899864981     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2014.04.004     Document Type: Article

References (42)

1. Garabedian L., Struyf S., Opdenakker G., Sozzani S., Van Damme J., Laureys G. Langerhans cell histiocytosis: a cytokine/chemokine-mediated disorder?. Eur. Cytokine Netw. 2011, 22:148-153.
2. Badalian-Very G., Vergilio J.A., Degar B.A., Macconaill L.E., Brandner B., Calicchio M.L., Kuo F.C., Ligon A.H., Stevenson K.E., Kehoe S.M., Garraway L.A., Hahn W.C., Meyerson M., Fleming M.D., Rollins B.J. Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood 2010, 116:1919-1923.
3. Satoh T., Smith A., Sarde A., Lu H.C., Mian S., Trouillet C., Mufti G., Emile J.F., Fraternali F., Donadieu J., Geissmann F. B-RAF mutant alleles associated with Langerhans cell histiocytosis, a granulomatous pediatric disease. PLoS One 2012, 7:e33891.
4. Sahm F., Capper D., Preusser M., Meyer J., Stenzinger A., Lasitschka F., Berghoff A.S., Habel A., Schneider M., Kulozik A., Anagnostopoulos I., Mullauer L., Mechtersheimer G., von Deimling A. BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis. Blood 2012, 120:e28-e34.
5. Auger I., Charpin C., Balandraud N., Martin M., Roudier J. Autoantibodies to PAD4 and BRAF in rheumatoid arthritis. Autoimmun. Rev. 2012, 11:801-803.
6. Henter J.I., Karlen J., Calming U., Bernstrand C., Andersson U., Fadeel B. Successful treatment of Langerhans'-cell histiocytosis with etanercept. N. Engl. J. Med. 2001, 345:1577-1578.
7. Andersson By U., Tani E., Andersson U., Henter J.I. Tumor necrosis factor, interleukin 11, and leukemia inhibitory factor produced by Langerhans cells in Langerhans cell histiocytosis. J. Pediatr. Hematol. Oncol. 2004, 26:706-711.
8. Rosso D.A., Karis J., Braier J.L., Henter J.I., Fadeel B. Elevated serum levels of the decoy receptor osteoprotegerin in children with Langerhans cell histiocytosis. Pediatr. Res. 2006, 59:281-286.
9. Coury F., Annels N., Rivollier A., Olsson S., Santoro A., Speziani C., Azocar O., Flacher M., Djebali S., Tebib J., Brytting M., Egeler R.M., Rabourdin-Combe C., Henter J.I., Arico M., Delprat C. Langerhans cell histiocytosis reveals a new IL-17A-dependent pathway of dendritic cell fusion. Nat. Med. 2008, 14:81-87.
10. Kannourakis G., Abbas A. The role of cytokines in the pathogenesis of Langerhans cell histiocytosis. Br. J. Cancer Suppl. 1994, 23:S37-S40.
11. de Graaf J.H., Tamminga R.Y., Dam-Meiring A., Kamps W.A., Timens W. The presence of cytokines in Langerhans' cell histiocytosis. J. Pathol. 1996, 180:400-406.
12. Egeler R.M., Favara B.E., van Meurs M., Laman J.D., Claassen E. Differential In situ cytokine profiles of Langerhans-like cells and T cells in Langerhans cell histiocytosis: abundant expression of cytokines relevant to disease and treatment. Blood 1999, 94:4195-4201.
13. Umemura M., Yahagi A., Hamada S., Begum M.D., Watanabe H., Kawakami K., Suda T., Sudo K., Nakae S., Iwakura Y., Matsuzaki G. IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis bacille Calmette-Guerin infection. J. Immunol. 2007, 178:3786-3796.
14. Sato K., Suematsu A., Okamoto K., Yamaguchi A., Morishita Y., Kadono Y., Tanaka S., Kodama T., Akira S., Iwakura Y., Cua D.J., Takayanagi H. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J. Exp. Med. 2006, 203:2673-2682.
15. Noonan K., Marchionni L., Anderson J., Pardoll D., Roodman G.D., Borrello I. A novel role of IL-17-producing lymphocytes in mediating lytic bone disease in multiple myeloma. Blood 2010, 116:3554-3563.
16. Murakami I., Morimoto A., Oka T., Kuwamoto S., Kato M., Horie Y., Hayashi K., Gogusev J., Jaubert F., Imashuku S., Al-Kadar L.A., Takata K., Yoshino T. IL-17A receptor expression differs between subclasses of Langerhans cell histiocytosis, which might settle the IL-17A controversy. Virchows Arch. 2013, 462:219-228.
17. Hogarty M.D. IL-17A in LCH: systemic biomarker, local factor, or none of the above?. Mol. Ther. 2011, 19:1405-1406.
18. Cua D.J., Tato C.M. Innate IL-17-producing cells: the sentinels of the immune system. Nat. Rev. Immunol. 2010, 10:479-489.
19. Zhu S., Qian Y. IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential. Clin. Sci. (Lond.) 2012, 122:487-511.
20. Olsson-Akefeldt S., Maisse C., Belot A., Mazzorana M., Salvatore G., Bissay N., Jurdic P., Arico M., Rabourdin-Combe C., Henter J.I., Delprat C. Chemoresistance of human monocyte-derived dendritic cells is regulated by IL-17A. PLoS One 2013, 8:e56865.
21. Tucci M., Stucci S., Savonarola A., Ciavarella S., Cafforio P., Dammacco F., Silvestris F. Immature dendritic cells in multiple myeloma are prone to osteoclast-like differentiation through interleukin-17A stimulation. Br. J. Haematol. 2013, 161:821-831.
22. Allen C.E., Mcclain K.L. Interleukin-17A is not expressed by CD207(+) cells in Langerhans cell histiocytosis lesions. Nat. Med. 2009, 15:483-484. (author reply 484-485.).
23. Fugier-Vivier I., Servet-Delprat C., Rivailler P., Rissoan M.C., Liu Y.J., Rabourdin-Combe C. Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells. J. Exp. Med. 1997, 186:813-823.
24. Wong K.L., Yeap W.H., Tai J.J., Ong S.M., Dang T.M., Wong S.C. The three human monocyte subsets: implications for health and disease. Immunol. Res. 2012, 53:41-57.
25. Ziegler-Heitbrock L., Ancuta P., Crowe S., Dalod M., Grau V., Hart D.N., Leenen P.J., Liu Y.J., Macpherson G., Randolph G.J., Scherberich J., Schmitz J., Shortman K., Sozzani S., Strobl H., Zembala M., Austyn J.M., Lutz M.B. Nomenclature of monocytes and dendritic cells in blood. Blood 2010, 116:e74-e80.
26. Honkanen J., Nieminen J.K., Gao R., Luopajarvi K., Salo H.M., Ilonen J., Knip M., Otonkoski T., Vaarala O. IL-17 immunity in human type 1 diabetes. J. Immunol. 2010, 185:1959-1967.
27. Rahman S., Gudetta B., Fink J., Granath A., Ashenafi S., Aseffa A., Derbew M., Svensson M., Andersson J., Brighenti S.G. Compartmentalization of immune responses in human tuberculosis: few CD8+ effector T cells but elevated levels of FoxP3+ regulatory t cells in the granulomatous lesions. Am. J. Pathol. 2009, 174:2211-2224.
28. Peters T.L., Mcclain K.L., Allen C.E. Neither IL-17A mRNA nor IL-17A protein are detectable in Langerhans cell histiocytosis lesions. Mol. Ther. 2011, 19:1433-1439.
29. Gullick N.J., Abozaid H.S., Jayaraj D.M., Evans H.G., Scott D.L., Choy E.H., Taams L.S. Enhanced and persistent levels of interleukin (IL)-17(+) CD4(+) T cells and serum IL-17 in patients with early inflammatory arthritis. Clin. Exp. Immunol. 2013, 174:292-301.
30. Auffray C., Sieweke M.H., Geissmann F. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu. Rev. Immunol. 2009, 27:669-692.
31. Fabrega E., Lopez-Hoyos M., San Segundo D., Casafont F., Pons-Romero F. Changes in the serum levels of interleukin-17/interleukin-23 during acute rejection in liver transplantation. Liver Transpl. 2009, 15:629-633.
32. Pini M., Fantuzzi G. Enhanced production of IL-17A during zymosan-induced peritonitis in obese mice. J. Leukoc. Biol. 2010, 87:51-58.
33. Chiricozzi A., Guttman-Yassky E., Suarez-Farinas M., Nograles K.E., Tian S., Cardinale I., Chimenti S., Krueger J.G. Integrative responses to IL-17 and TNF-alpha in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis. J. Invest. Dermatol. 2011, 131:677-687.
34. Kebir H., Kreymborg K., Ifergan I., Dodelet-Devillers A., Cayrol R., Bernard M., Giuliani F., Arbour N., Becher B., Prat A. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat. Med. 2007, 13:1173-1175.
35. Rossol M., Kraus S., Pierer M., Baerwald C., Wagner U. The CD14(bright) CD16+ monocyte subset is expanded in rheumatoid arthritis and promotes expansion of the Th17 cell population. Arthritis Rheum. 2012, 64:671-677.
36. Xia Z., Liu Q., Berger C.T., Keenan B.T., Kaliszewska A., Cheney P.C., Srivastava G.P., Castillo I.W., De Jager P.L., Alter G. A 17q12 allele is associated with altered NK cell subsets and function. J. Immunol. 2012, 188:3315-3322.
37. Zhang X., Jin J., Peng X., Ramgolam V.S., Markovic-Plese S. Simvastatin inhibits IL-17 secretion by targeting multiple IL-17-regulatory cytokines and by inhibiting the expression of IL-17 transcription factor RORC in CD4+ lymphocytes. J. Immunol. 2008, 180:6988-6996.
38. Scotta C., Esposito M., Fazekasova H., Fanelli G., Edozie F.C., Ali N., Xiao F., Peakman M., Afzali B., Sagoo P., Lechler R.I., Lombardi G. Differential effects of rapamycin and retinoic acid on expansion, stability and suppressive qualities of human CD4(+)CD25(+)FOXP3(+) T regulatory cell subpopulations. Haematologica 2013, 98:1291-1299.
39. De Filippi P., Badulli C., Cuccia M., De Silvestri A., Dametto E., Pasi A., Garaventa A., del Prever A.B., Todesco A., Trizzino A., Danesino C., Martinetti M., Arico M. Specific polymorphisms of cytokine genes are associated with different risks to develop single-system or multi-system childhood Langerhans cell histiocytosis. Br. J. Haematol. 2006, 132:784-787.
40. Lehrnbecher T., Salzmann-Manrique E., Soerensen J., Beutel K., Janka G., Gadner H., Minkov M. Variant alleles of cytokine genes influence risk and clinical course of Langerhans cell histiocytosis. Br. J. Haematol. 2012, 156:138-141.
41. Santarlasci V., Maggi L., Capone M., Querci V., Beltrame L., Cavalieri D., D'aiuto E., Cimaz R., Nebbioso A., Liotta F., De Palma R., Maggi E., Cosmi L., Romagnani S., Annunziato F. Rarity of human T helper 17 cells is due to retinoic acid orphan receptor-dependent mechanisms that limit their expansion. Immunity 2012, 36:201-214.
42. Zaretsky M., Etzyoni R., Kaye J., Sklair-Tavron L., Aharoni A. Directed evolution of a soluble human IL-17A receptor for the inhibition of psoriasis plaque formation in a mouse model. Chem. Biol. 2013, 20:202-211.